Articles

1 article
specialty-drugspharmacy-costspbm-transparency
Specialty Drug Pipeline 2027: The Claims Hitting Your Plan Next Year
Specialty drugs now exceed 50% of employer pharmacy spend. With oncology, GLP-1s, and $3 million gene therapies in the 2027 pipeline, here's what self-funded employers need to do before it hits.
Jun 18, 20262 min readRead →